Skip to main content

Table 3 Clinicopathological correlation of TET3 to ovarian cancer

From: TET3 inhibits TGF-β1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells

    Immunohistochemical composite scores  
Clinicopathological parameters of ovarian cancer Overall Positivitya P value Mean SD P value
Ageb      
  < 50 (n = 25) 17 (68 %) 0.3793 0.65 0.77 0.9822
  ≥ 50 (n = 39) 31 (78.5 %)   0.66 0.62  
 NA (n = 4)      
Gradec      
 G1 (n = 7) 7 (100 %) 0.024* 0.73 0.50 0.2409
 G2 (n = 26) 23 (88.5 %)   0.93 0.76  
 G3 (n = 29) 18 (62.1 %)   0.59 0.76  
  1. aPercentage of cases with more than 5 % positive cells. bFisher’s Exact Test (two-tailed). ct-test or one-way ANOVA (two-tailed). NA non-available
  2. * P < 0.05